Document is current

Article History

Received: 30 December 2022

Accepted: 3 April 2023

First Online: 17 May 2023

Declarations

:

: Ethical approval was not required as data are publicly available.

: Not applicable.

: TPD is a member of the electronic media committees of The Danish Headache Society, The European Headache Federation, and The International Headache Society. APA is a member of the electronic media committee of The International Headache Society, has received speaker honoraria, funding for travel, and honoraria for participation in advisory boards sponsored by eNeura, Allergan, AbbVie, Eli Lilly, Novartis and Neuresta. ABO is a member of the electronic media committee of The International Headache Society. RES has served as a paid consultant to Eli Lilly as a member of the Data Monitoring Committees for galcanezumab multi-center clinical trials for both cluster headache and migraine, as well as on the advisory committee for the OVERCOME study. RES has received financial or authorship compensation as a research consultant for Eli Lilly and Lundbeck. CL has received fees as speaker or for participation to advisory boards from Allergan, Eli-Lilly, Novartis, Pfizer, Teva; President of The European Headache Federation. FMA has received lecturing fee and/or served as advisory board member for Teva, Lundbeck, Eli Lilly and Novartis; principal investigator for phase 4 trials for Novartis and Teva; board member of The European Headache Federation.